baber/WOPTO huggingface dataset:
Patent NZ-520996-A (NZ)
Title: Sailboat fin rotatable about ballast support
Inventor: HOOD FREDERICK E
IPC: B63B41/00
Filed: 2002-08-26
Abstract: A keel appendage comprising an elongated four-sided symmetrical diamond shaped ballast support member adapted to be fixed at its upper end to a canoe body in perpendicular relationship to the longitudinal axis of said canoe body, a ballast member fixed to the outer end of said ballast support member, the leasing and trailing edges of said ballast support member being pointed and disposed perpendicular to the longitudinal axis of said canoe body, a hollow hydrodynamic rotatable fin rigid from its leading edge to its trailing edge completely surrounding said ballast support member in rotatable sliding contact with such ballast support member whereby the undesirable dynamic drag of the ballast support member is eliminated when the canoe body is sailing.
Patent NZ-521549-A (NZ)
Title: Monitoring auditory evoked potentials for indicating the depth of anaesthesia of a patient
Inventor: JENSEN ERIK WEBER
IPC: A61B5/0476
Filed: 2000-11-15
Abstract: A method and an apparatus for extracting signals which are indicative of the level of consciousness of a patient comprises subjecting the patient to a repetitive audio stimulus, monitoring AEP produced by the patient using an autoregressive model with exogenous input, and then calculating an index (AAI), which is displayed or used otherwise, indicative of the anaesthetic depth.
Patent NZ-527497-A (NZ)
Title: Improvements in/or relating to a toggle latch
Inventor: ARTHUR JENNY MAREE
IPC: A47D7/02
Filed: 2003-08-11
Abstract: A toggle assembly (12) for a toggle latch (10). The toggle assembly comprises an elongated toggle (20) having a first cord (22) extending from a first point of the toggle located inwardly from its ends, the toggle being biased into a generally transverse orientation relative to the first cord, at least when freely suspended or pulled by the first cord, and a second cord (24) extending from a second point of the toggle located at or towards and end thereof, the first and second points being spaced apart along the length of the toggle, whereby a pulling on the second cord in a direction away from the toggle tends to align the toggle with the direction of the pulling on the second cord. The toggle latch may be used with a drop-sided cot.
Patent NZ-528607-A (NZ)
Title: Method of treating inflammatory GI disorders using topically active corticosteroids to reduce symptoms without causing the side effects associated with systemic steroid administration
Inventor: MCDONALD B GEORGE
IPC: A61K9/20
Filed: 2002-03-15
Abstract: Disclosed is the use of at least two separate dosage forms of a topically active corticosteroid in the manufacture of a medicament for the treatment of inflammatory disorders of the gastrointestinal tract and/or bowel of a patient.
Patent NZ-531593-A (NZ)
Title: Actuator device and method of manufacturing cells for view through window covering
Inventor: COREY JOHN A
IPC: E06B9/262
Filed: 2002-12-23
Abstract: An actuator device is provided for use in a view-through window covering having a plurality of cells. The actuator device includes at least one cooperating pair of control members including a first control member that engages an upper portion of each cell and a second control member that engages a lower portion of each cell. The cooperating pair of control members are engaged with the cells along a plane parallel to the plane of the window covering, whereby relative movement of the control members modifies the size of the space between the cells. A cell and method of manufacturing a cell for a multi-cell window covering is also disclosed. The method includes the steps of providing a flexible material, stiffening a portion of the flexible material, and creating at least one control engagement formation and at least one control clearance formation in axially extending sections of the stiffened flexible material that will become an upper portion and a lower portion of the cell. The method is further defined by folding the flexible material to create a closed element and securing the flexible material to itself to maintain the shape of the closed element.
Patent NZ-533567-A (NZ)
Title: Spiroazacyclic compounds as monoamine receptor for modulating 5-HT2A receptor-mediated events
Inventor: SCHLIENGER NATHALIE
IPC: A61P25/22
Filed: 2002-12-23
Abstract: The disclosure relates to spiroazacyclic compounds of formula (I) as monoamine receptor modulators, wherein the variables are as defined in the specification; pharmaceutical compositions comprising the same; use of the said compounds in the manufacture of a medicament for treating a disease condition associated with a monoamine receptor; methods of inhibiting an activity of a monoamine receptor with said compounds; and methods for identifying a subject suitable for treatment using said compounds.
Patent NZ-535371-A (NZ)
Title: Prothrombin activating protein
Inventor: MASCI PAUL PANTALEONE
IPC: A61L17/00
Filed: 2003-04-03
Abstract: Provided is the use of an isolated preparation of a snake venom protease (SVP) comprising one or more of a light chain which shares at least 90% sequence identity with a light chain sequence of SEQ ID NO: 2, and a heavy chain which shares at least 85% sequence identity with a heavy chain sequence of SEQ ID NO: 2 and which does not require calcium, phospholipid or factor Va for activity, in the manufacture of a medicament to increase clotting and/or decrease blood or fluid loss in a subject, wherein the preparation has less than 30% contaminating protein. Further provided are variants of this prothrombin activating protein, and kits containing the inventive protein as well as devices for delivery of the protein to a subject.
Patent NZ-538417-A (NZ)
Title: A concrete railway sleeper and a method of designing it
Inventor: STEVENS NICHOLAS JOHN
IPC: E01B3/28
Filed: 2003-08-22
Abstract: A method of designing a concrete sleeper, the method including the steps of determining a loading spectrum for a length of railway track; choosing a trial sleeper design having known structural properties including bending capacity at a rail seat and the tendon and concrete stresses for a range of bending moments; determining a load distribution for the railway track including calculating a bending moment in the sleeper for a predetermined load at a known distance from the sleeper; calculating an ultimate load based on the loading spectrum; comparing the ultimate load with the bending capacity at the rail seat for the sleeper; determining fatigue life of the sleeper based on the loading spectrum, load distribution, and tendon and concrete stresses; comparing the calculated fatigue life of the sleeper with predetermined safe fatigue life values.
Patent NZ-544451-A (NZ)
Title: Uses of a novel eimeria gene and corresponding protein
Inventor: GREIF GISELA
IPC: C07K16/20
Filed: 2004-06-30
Abstract: Disclosed is a polynucleotide encoding an oocyst sporocyst protein of Eimeria tenella comprising: a) the sequence of SEQ ID NO: 1; b) a polynucleotide which exhibits a sequence identity of more than 95% with the polynucleotide having the sequence of SEQ ID NO: 1; c) a polynucleotide which hybridizes, under highly stringent conditions, with the polynucleotide having the sequence of SEQ ID NO: 1; or, d) a polynucleotide which differs from a polynucleotide having the sequence of SEQ ID NO: 1 due to the degeneracy of the genetic code. Also disclosed are vectors and host cells comprising the polynucleotide described above.
Patent NZ-551012-A (NZ)
Title: Use of S-methyl-dihydro-ziprasidone administered via either the oral, parenteral (such as subcutaneous, intravenous, intramuscular, intrasternal and infusion techniques), rectal, intranasal or topical routes in doses ranging from 0.5 to 500 mg per day
Inventor: PRAKASH CHANDRA AGGARWAL
IPC: A61P27/02
Filed: 2001-05-28
Abstract: Disclosed is the use of S-methyl-dihydro-ziprasidone and its pharmaceutically acceptable salts for the manufacture of a medicament for the treatment of psychiatric and ocular disorders. More specifically, it relates to the use of such compound and its pharmaceutically acceptable salts for the treatment of a disorder or condition selected from: schizophrenia, anxiety disorders such as generalized anxiety disorder, panic disorder, posttraumatic stress disorder and phobias (e.g., social phobia, agoraphobia etc.); psychotic episodes of anxiety: anxiety, agitation, excessive aggression, tension, or social or emotional withdrawal associated with psychosis; psychotic mood disorders such as severe major depressive disorder; mood disorders associated with psychotic disorders such as acute mania and depression associated with bipolar disorder, and mood disorders associated with schizophrenia; behavioral disturbances associated with mental retardation, autistic disorder, and conduct disorder; dementias such as dementias associated with Alzheimer's disease; drug-induced and neurodegeneration based dyskinesias; obsessive compulsive disorder; Tourette's syndrome; glaucoma; and ischemic retinopathy. (62) Divided Out of 539755
Patent NZ-555656-A (NZ)
Title: Elliptical exercise device with adjustable strokes
Inventor: CHUANG JIN CHENG
Filed: 2007-06-06
Abstract: An exercise device comprising a base (10), a spindle (12), two cranks (30), two handles (40), two foot supports (54), and two levers (32).The base (10) includes an upright support (13) where two handles (40) with hand grips (42) are connected though a spindle (12) to allow the handles (40) to be pivoted and swung relative to the upright support (13) of the base (10).The two cranks (30) are coupled to the rear portion of the upright support (11) with a shaft (21), which is connected to the handles (40) via the pivot rod (31) and to the middle portion (51) of the handles (40). The middle potion of the handle (51) is coupled to the two foot supports (54), which move cyclically relative to the upright support (11).The two levers (32), where the first end is connected to the pivot rod (31) of the crank (30) and the second end is coupled to the middle portion (51) to form a polygonal coupling structure with the handles (40).
Patent NZ-560281-A (NZ)
Title: Corpse treatment device
Inventor: OKAMOTO TOSHIKI
IPC: A61G17/00
Filed: 2005-01-18
Abstract: A corpse treatment device is disclosed. The corpse treatment device comprises a water-absorbing column which expands as it absorbs water, a separate water-absorbing agent, a guide member, a closing member, and a rod shaped push member. The guide member is cylindrical and has openings at first and second ends. The push member is inserted through the opening in the second end of the guide member, and is able to, in use, push the column and the water-absorbing agent out of the first end of the guide member and into a body cavity. The corpse treatment device is configured so that the column pushed through the opening of the guide member into the body cavity absorbs water in internal contents in the body cavity to expand until plugging the cavity and the water-absorbing agent absorbs water in the internal contents, thereby preventing the internal contents from leaking out of the cavity.
Patent NZ-564067-A (NZ)
Title: Inhalator capsules
Inventor: LANCESSEUR DIDIER
IPC: A61K9/48
Filed: 2006-05-17
Abstract: A capsule 1, in particular for the packaging of inhalation formulations, in which at least one cavity is enclosed by a wall 2, wherein at least one portion of the wall 2 has a polymer composition that contains at least one adsorbent.
Patent NZ-564347-A (NZ)
Title: Utility cabinet for electrical fuse switches with cap secured on base having rack for switches
Inventor: WIN SPENCER GEORGE
Filed: 2006-06-27
Abstract: A utility cabinet has a base cabinet, having a top and a bottom, a cap having a top and a bottom, a rack to which electrical fuse switches and other electrical components may be attached. The rack protrudes above the base and is secured to the base. Biased protrusions are provided on the rack for securing the cap and base together.
Patent NZ-566169-A (NZ)
Title: Parasiticide composition
Inventor: LAU KAI KIN
Filed: 2008-02-25
Abstract: Disclosed are organophosphate compositions where the organophosphate is presented in the form of a drench for the prevention or control of endo- and ecto- parasites in warm blooded animals. In particular the invention relates to a non-aqueous suspension composition comprising: a parasiticidally effective amount of at least one organophosphate; on or more organic solvents selected from the group consisting of medium chain triglycerides, alcohols, C1-C18 pyrrolidones, alkyl ethers, glycol ethers, fatty acid esters and glycerol fatty acid esters; one or more stabilising agents; and one or more surfactants.
Patent NZ-571566-A (NZ)
Title: Imidazolothiazole compounds for the treatment of disease
Inventor: BHAGWAT SHRIPAD
IPC: C07D513/04
Filed: 2007-03-16
Abstract: Disclosed is a pyrazole compound of formula (I), wherein bond b is a single bond or double bond; X is -S-, -N(R5)- or -O-; Z1 and Z3 are each independently -N(R5 )-, -(CH2)q, -O-, -S-, or a direct bond; Z2 is -C(O)- or -C(S)-; m is an integer from 1 to 2; n is an integer from 1 to 3; each q is independently an integer from 1 to 4; R0 is hydrogen, halo, hydroxy, alkyl, or alkoxy; each R1, R2, R3 and R4 are defined in the specification or a single stereoisomer, a mixture of stereoisomers, a racemic mixture of stereoisomers, a solvate, a hydrate, or a pharmaceutically acceptable salt thereof. Also disclosed is the use of said compound in the treatment of acute myeloid leukemia, chronic myeloid leukemia, thyroid cancer, stomach cancer, gastrointestinal stromal tumor, colorectal cancer, prostate cancer, breast cancer, ovarian cancer, pancreatic cancer, lung cancer, non-small cell lung cancer, liver cancer, renal cancer, bladder cancer, esophageal cancer, lymphoma or myeloma, acute lymphoblastic leukemia, myelodysplastic syndrome, myelodysplastic leukemia, small cell lung cancer, glioma, glioblastoma, melanoma, renal cell carcinoma, endometrial cancer, idiopathic hypereosinophilic syndrome, chronic eosinophilic syndrome, systemic mastocytosis, Langerhans cell histiocytosis, Kaposi's sarcoma, multiple endocrine neoplasia, myeloproliferative disease, mast cell leukemia, or acute leukemia selected from promyelocytic leukemia, myeloblastic leukemia, myelomonocytic leukemia, erythroleukemia, monocytic leukemia, megakaryoblastic leukemia.
Patent NZ-574656-A (NZ)
Title: N-((1R,2S,5R)-5-(isopropyl(methyl)amino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-1-yl)cyclohexyl)acetamide, crystal forms and pharmaceutically acceptable salts thereof
Inventor: YANG MICHAEL G
IPC: C07D207/273
Filed: 2007-07-26
Abstract: Disclosed is the compound N-((1R,2S,5R)-5-(isopropyl(methyl)amino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-1-yl)cyclohexyl)acetamide, its crystal forms and pharmaceutically acceptable salts thereof.
Patent NZ-576418-A (NZ)
Title: Device and method for placing containers of collapsible type in a distribution unit
Inventor: GUSTAFFSON PER
IPC: B65B35/36
Filed: 2007-11-07
Abstract: Disclosed is a device which places filled and sealed containers of a collapsible type in a distribution unit. The device is used to move containers to a packing position in which the containers are suspended along a horizontal longitudinal axis. The device comprises a gripping unit (6). The gripping unit (6) comprises a number of fingers pairs (14) that corresponds to the number of containers in the packing position. In a non-gripping state of the gripping unit (6), each finger pair (14) has a finger gap (17) which allows a container to pass in which each finger pair (14) is arranged to make a squeezing motion. The gripping unit (6) is operable to a gripping state in which each finger pair (14) is arranged to make a squeezing motion to grip a container on opposite sides of the container. The container is gripped with such a squeezing force that the contents of the container form an inner counter-pressure extending between the fingers to provide a well-defined grip.
Patent NZ-583501-A (NZ)
Title: Antimicrobial composition comprising lauric arginate (lae) and nisin
Inventor: MYGIND TINA
IPC: A23B7/154
Filed: 2008-09-03
Abstract: Disclosed herein is a composition comprising an antimicrobial compound LAE (also known as Mirenat-N, lauric arginate, N-Lauroyl-L-arginine ethyl ester monohydrochloride and lauramide arginine ethyl ester) and nisin. Such compositions are useful for inhibiting microbial growth in foodstuffs. Also disclosed are processes for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material as well as use of said compound and nisin.
Patent NZ-600683-A (NZ)
Title: Reactor comprising a rotor
Inventor: OLSSON ANDERS
IPC: B02C13/04
Filed: 2010-12-21
Abstract: A reactor (1) for the separation of material from a composite raw material is disclosed. The reactor (1) comprises at least one reaction chamber (2) and at least one rotor (5) with a hammer (4). The rotor (5) comprises at least one shaft which extends through the housing (6) on one side, to be supported by bearings (12). A detachable lid part (7) may be removed to inspect the inside of the reactor (1).
Patent NZ-604204-A (NZ)
Title: Improvements to window systems
Inventor: LEWIS WARREN PAUL
IPC: E06B5/00
Filed: 2011-12-10
Abstract: A window system 40 includes a glass panel 12, bottom and top frame members 48 and 50, and side frame members 52 and 54 surrounding the glass panel 12, and sill and head reveal members and side jamb members 26 and 28 which are fitted into channel sections of the frame members 48, 50, 52, and 54 and face orthogonal to the plane of the glass panel 12. The frame members 48, 50, 52, and 54 are joined at their corners with corner joiners 42 which are designed to give sufficient strength such that the total load from the glass window panel is transferred from the bottom edges of the glass panel directly through the side jamb members 26, and 28 to the side members of a wall opening in a building. Hence there is no need to provide a support member along the bottom of the glass panel to transfer the weight of the glass panel back to wall opening.
Patent NZ-615588-A (NZ)
Title: Auxin plant growth regulators
Inventor: OZGA JOCELYN
IPC: A01G22/22
Filed: 2012-03-21
Abstract: Disclosed is a method of enhancing fruit and/or seed yield in a flowering plant comprising a gibberellin response pathway, comprising the step of applying an effective amount of a composition comprising an auxin selected from the group consisting of 4-chloro-indole-3-acetic acid and 4-methyl-indole-3-acetic acid and combinations thereof to the plant, or a portion thereof, or a locus thereof, at or before a flowering or fruiting stage of the plant.
Patent NZ-624137-A (NZ)
Title: Plasticizers for adhesive, coating and sealant compositions applied to asphalt
Inventor: STUART JONATHAN T
IPC: C09J175/04
Filed: 2012-10-31
Abstract: Disclosed is an asphalt adhesive, coating or sealant composition comprising a base polymer or copolymer material and at least one ester containing plasticiser having a molecular weight less than about 3,000 grams per mole and a structure according to formula (I). The composition resists softening of the asphalt at elevated temperatures up to 140°F (60°C). In a particular embodiment, the plasticizer is oxydiethylene dibenzoate, castor oil, and glycerol triacetate. In a particular embodiment, the base polymer or copolymer that includes polyurethanes, silylated polyurethanes,and silylated polyethers.
Patent NZ-626279-A (NZ)
Title: Quinoline derivatives as pde10a enzyme inhibitors
Inventor: KEHLER JAN
IPC: C07D471/04
Filed: 2012-12-21
Abstract: The disclosure relates to 7-(2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinolone, 6-[2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a] pyrazin-2-yl)-ethyl]-[1,3]dioxolo[4,5-g]quinolone (figure), 2-(2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl)-6-fluoroquinoline and 2-(2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl)-7-fluoroquinoline. disorders. These compounds can be used as PDE10A enzyme inhibitors, and as such are useful to treat neurodegenerative and psychiatric disorders. The disclosure also provides pharmaceutical compositions comprising compounds of the invention.
Patent NZ-629535-A (NZ)
Title: Bacterial vaccine
Inventor: GARCIA LARA JORGE
IPC: A61P31/04
Filed: 2013-04-09
Abstract: A vaccine composition comprising a Clostridium difficle polypeptide represented by SEQ ID NO: 119 (GCP) and SEQ ID NO: 149 (Div1B) (sequences as defined in the specification).
Patent NZ-701454-A (NZ)
Title: Method and apparatus for measuring and controlling electrolytically-active species concentration in aqueous solutions
Inventor: MCNEEL THOMAS E
IPC: G01N27/42
Filed: 2013-04-26
Abstract: A method is provided for measuring an electrolytically-active species concentration in an aqueous or non-aqueous solution for use in providing control of the concentration of the species in a source solution thereof based on the measurements. In the method, a sample containing an electrolytically-active species is added into a measurement cell that has a working electrode and an auxiliary electrode, and a constant current is applied to the measurement cell while the working and auxiliary electrodes are in contact with the sample with monitoring of voltage difference across the electrodes until a change in the voltage difference is detected. A feedback signal is generated based on a parameter of the change in the voltage difference that is directly proportional to the amount of the electrolytically-active species in the sample, which can be used for process control. The feedback signal is used to control the amount of the electrolytically-active species, or a precursor thereof, or a component thereof, or a reactant for producing the electrolytically-active species in the aqueous or non-aqueous solution. An apparatus is also described.
Patent NZ-702135-A (NZ)
Title: Intermediates and processes for preparing 5-bromo-4-chloro-3-nitro-1h-pyrrolo[2,3-b]pyridine
Inventor: HAN CHONG
IPC: C07D471/04
Filed: 2013-04-22
Abstract: A process for preparing 5-bromo-4-chloro-3-nitro-1H-pyrrolo[2,3-b]pyridine of Formula I, comprising the step of subjecting 4-chloro-3-nitro-1H-pyrrolo[2,3-b]pyridine of Formula II to a bromination, to yield 5-bromo-4-chloro-3-nitro-1H-pyrrolo[2,3-b]pyridine of Formula I.
Patent NZ-704018-A (NZ)
Title: Extendable vehicle roll-over protection structure
Inventor: PÉREZ DE LARRAYA SAGÜÉS CARMELO
IPC: G01C9/00
Filed: 2012-11-13
Abstract: The invention relates to an extendable vehicle roll-over protection structure formed by a closed V-shaped structure (1), in which both the vertical side segments (4) and the horizontal upper segment (7) can be extended and retracted telescopically, with both the width and the height of the structure being increased as it moves from the retracted position to the extended position. The lower end of the vertical side tubular elements (4) of the structure are suitably secured to the chassis of the associated vehicle (2). The structure (1) is extended prior to a pre-determined inclination of the vehicle via the pressing of an inclination sensor and by means of an activation algorithm or command.
Patent NZ-717751-A (NZ)
Title: Materials and methods for respiratory disease control in canines
Inventor: CRAWFORD PATTI C
IPC: C12N7/00
Filed: 2006-10-19
Abstract: Disclosed is an isolated influenza virus that is capable of infecting a canid animal